Pyruvate Dehydrogenase Complex Deficiency: Clinical Trials

5 trials for Pyruvate Dehydrogenase Complex Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 available, 1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Completed 1
Phase 31Active not recruiting 1

Follow Pyruvate Dehydrogenase Complex Deficiency: new trials by email Literature Review of Pyruvate Dehydrogenase Complex Deficiency trials Research Report on Pyruvate Dehydrogenase Complex Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency
Triheptanoin - Pyruvate Dehydrogenase Complex Deficiency
Phase 1RecruitingJirair Krikor Bedoyan62024-07-112026-02-17
Natural History Study of Pyruvate Dehydrogenase Deficiency
Pyruvate Dehydrogenase Complex Deficiency, Pyruvate Dehydrogenase E1 Alpha Deficiency
UnknownGreat Ormond Street Hospital for Children NHS Foundation Trust502020-11-012023-12-05
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
Dichloroacetate (DCA), Placebo, Genotype - Pyruvate Dehydrogenase Complex Deficiency
Phase 3Active not recruitingSaol Therapeutics Inc342020-07-142025-05-04
Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency.
sodium phenylbutyrate - Pyruvate Dehydrogenase Complex Deficiency
Phase 2CompletedFondazione Telethon12018-10-012021-10-13
Expanded Access Treatment Protocol With DCA for Patients With PDCD
Dichloroacetate (DCA) - Pyruvate Dehydrogenase Complex Deficiency
AvailableSaol Therapeutics Inc2025-05-08

Narrower conditions

Pyruvate Dehydrogenase Complex Deficiency Disease (5)  ·  Pyruvate Dehydrogenase E1 Alpha Deficiency (1)  ·  Pyruvate Dehydrogenase E1-Beta Deficiency (1)  ·  Pyruvate Dehydrogenase E2 Deficiency (1)  ·  Pyruvate dehydrogenase phosphatase deficiency (1)

Broader conditions

Brain Diseases (5)  ·  Brain Diseases, Metabolic (5)  ·  Brain Diseases, Metabolic, Inborn (5)  ·  Carbohydrate Metabolism, Inborn Errors (5)  ·  Central Nervous System Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Genetic Diseases, X-Linked (5)  ·  Heredodegenerative Disorders, Nervous System (5)  ·  Intellectual Disability (5)  ·  Metabolic Diseases (5)  ·  Metabolism, Inborn Errors (5)  ·  Mitochondrial Diseases (5)  ·  Nervous System Diseases (5)  ·  Neurobehavioral Manifestations (5)

Interventions

Dichloroacetic Acid (2)  ·  4-phenylbutyric acid (1)  ·  Genotype (1)  ·  triheptanoin (1)

Sponsors

Saol Therapeutics Inc (2)  ·  Fondazione Telethon (1)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  Jirair Krikor Bedoyan (1)

Countries

United States (2)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Jirair Bedoyan, MD, PhD (1)  ·  Kiki Diorgu, M.D. (1)  ·  Richard Neibeger, MD (1)  ·  Shamima Rahman, PhD (1)